Eli Lilly and Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr891.30 | kr696.07 | 7.71% | 14 | kr3.86T |
| MRK | Merck | Outperform |
2
|
$126.88 | $130.51 | 9.95% | 11 | $318.60B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£112.68 | £165.99 | 43.61% | 16 | £169.69B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$574.59 | $591.94 | 5.99% | 1 | $207.95B |
| NOVN | Novartis | Hold |
10
|
CHF88.94 | CHF105.00 | 19.07% | 9 | CHF181.47B |
| ROG | Roche Holding | Hold |
16
|
CHF229.70 | CHF307.83 | 18.63% | 9 | CHF178.76B |
| ABT | Abbott Laboratories | Outperform |
9
|
$107.59 | $118.92 | 17.58% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$26.32 | $32.87 | 15.88% | 6 | $147.23B |
| AMGN | Amgen | Outperform |
4
|
$273.54 | $303.65 | 15.98% | 8 | $144.25B |
| SAN | Sanofi | Outperform |
16
|
88.85€ | 102.80€ | 22.68% | 9 | 108.49€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.99 | $58.15 | 12.27% | 10 | $99.17B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.03 | $87.82 | 19.35% | 14 | $83.25B |
| GSK | GSK | Outperform |
12
|
£16.51 | £17.30 | 18.11% | 12 | £65.34B |
| ZTS | Zoetis | Outperform |
18
|
$149.56 | $220.47 | 47.77% | 5 | $66.94B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.19k | ¥4.92k | 18.61% | 0 | ¥8.10T |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.48k | Rp1.52k | 6.76% | 25 | Rp3.65T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.12k | ¥4.74k | 10.38% | 0 | ¥6.38T |
| MRNA | Moderna | Outperform |
16
|
$107.89 | $135.42 | 15.30% | 1 | $38.83B |
| BAYN | Bayer | Hold |
5
|
27.35€ | 45.15€ | 17.00% | 4 | 25.86€B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$146.07 | $245.24 | 47.19% | 7 | $18.26B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.01 | $11.59 | 22.98% | 9 | $14.57B |
| DGX | Quest Diagnostics | Outperform |
10
|
$136.70 | $141.17 | 5.34% | 8 | $15.18B |
| BGNE | BeiGene | Buy |
6
|
$138.99 | $285.19 | 97.86% | 2 | $13.53B |
| 4507 | Shionogi & | Outperform |
18
|
¥7.34k | ¥7.12k | 8.95% | 0 | ¥2.02T |
| BIM | bioMérieux | Outperform |
18
|
101.40€ | 105.55€ | 12.18% | 1 | 11.76€B |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
39.90€ | 41.13€ | -3.51% | 12 | 10.74€B |
| 4523 | Eisai | Outperform |
18
|
¥6.09k | ¥9.58k | 37.93% | 0 | ¥1.69T |
| IPN | Ipsen | Outperform |
17
|
111.40€ | 127.95€ | 5.03% | 0 | 8.95€B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$74.01 | $79.10 | 21.61% | 10 | $6.79B |
| 4528 | Ono Pharmaceutical | Hold |
18
|
¥2.29k | ¥2.76k | 6.96% | 0 | ¥1.05T |
| EXEL | Exelixis | Outperform |
16
|
$23.29 | $26.44 | 15.93% | 5 | $6.21B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$92.29 | $85.71 | 8.35% | 5 | $5.53B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr611.00 | kr357.00 | 33.39% | 2 | kr36.34B |
| HALO | Halozyme Therapeutics | Outperform |
11
|
$38.97 | $47.50 | 24.45% | 3 | $4.91B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr33.00 | kr190.00 | 10.61% | 6 | kr32.62B |
| ALKS | Alkermes | Outperform |
10
|
$24.26 | $33.27 | 40.15% | 3 | $4.04B |
| NNI | Nelnet | Hold |
12
|
$94.88 | $95.00 | -5.14% | 1 | $3.51B |
| VIRP | Virbac | Outperform |
18
|
359.00€ | 348.34€ | 2.79% | 5 | 3.05€B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.53 | $9.50 | 11.37% | 5 | $3.19B |
| 4506 | Sumitomo Pharma | Underperform |
18
|
¥464.00 | ¥0.00 | 5.82% | 0 | ¥396.90B |
| PFIZER | Pfizer | Outperform |
18
|
Rp4.15k | Rp4.53k | 18.87% | 3 | Rp207.63B |
| 300529 | Jafron Biomedical | Buy |
18
|
¥22.58 | ¥26.62 | 17.89% | 0 | ¥17.70B |
| INDV | Indivior PLC | Buy |
14
|
£15.20 | £28.89 | 107.24% | 4 | £1.93B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$40.91 | $69.00 | 51.55% | 0 | $1.96B |
| VETO | Vetoquinol | Outperform |
18
|
98.90€ | 106.50€ | 9.20% | 0 | 1.14€B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| HIMX | Himax Technologies | Outperform |
13
|
$4.91 | $7.00 | 26.27% | 1 | $943.59M |
| 524735 | Hikal | Buy |
18
|
Rp314.80 | Rp328.00 | 4.83% | 1 | Rp36.83B |
| AMRN | Amarin | Hold |
8
|
$0.88 | $2.05 | 13.64% | 1 | $352.89M |
| PBYI | Puma Biotechnology | Hold |
10
|
$5.13 | $4.67 | -22.03% | 2 | $295.89M |
| VNDA | Vanda Pharmaceuticals | - |
0
|
$4.63 | $4.25 | -46.22% | 0 | $294.02M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.18 | $10.86 | 266.97% | 3 | $266.16M |
| OOMA | Ooma | Buy |
9
|
$6.83 | $18.60 | 119.62% | 4 | $255.16M |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.78 | $4.60 | 166.85% | 1 | $244.39M |
| EDT | Spectral Medical | Buy |
0
|
C$0.44 | C$1.60 | 309.09% | 0 | C$167.15M |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£31.56 | £0.00 | -100.00% | 0 | £3.30B |
| CODA | Coda Octopus Group | Buy |
0
|
$5.69 | $8.00 | 75.75% | 0 | $66.93M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.18 | $0.65 | 455.56% | 0 | $56.27M |
| CTSO | Cytosorbents | Outperform |
11
|
$0.88 | $4.50 | 240.91% | 1 | $52.73M |
| PMN | ProMIS Neurosciences | Buy |
6
|
$2.05 | $18.49 | 486.34% | 0 | $37.20M |
| ECOR | electroCore | Buy |
0
|
$5.66 | $22.75 | 368.20% | 1 | $33.91M |
| POXEL | Poxel | - |
9
|
0.77€ | 3.50€ | -100.00% | 0 | 25.34€M |
| ACST | Acasti Pharma | Buy |
0
|
$2.88 | $16.34 | 179.86% | 0 | $26.98M |
| ORGS | Orgenesis | - |
6
|
$0.28 | $9.00 | -46.43% | 0 | $16.26M |
| LXXG.Q | LexaGene Holdings | - |
4
|
$0.11 | $0.75 | -100.00% | 0 | $11.34M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.85 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| ULGX | Urologix | - |
0
|
$0.00 | $1.50 | 0.00% | 0 | $0.00M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |